Rock Creek Pharmaceuticals, Inc. filed a motion in the US Bankruptcy Court for the sale of its certain assets on December 21, 2018. The debtor seeks the Court’s approval for the sale of its certain assets to Xcaliber International, Ltd. pursuant to the asset purchase agreement, dated December 21, 2018. The debtor’s assets include rights and interests in certain escrow funds in the additional escrow accounts. The buyer shall pay 23% of the principal in the escrow accounts as of the closing date. Michael J. Merchant and Brett M. Haywood of Richards, Layton & Finger, P.A represented the buyer as legal advisors.